Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-18

Clinical Trial Update: Bela 8 Week Dosing [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Bela 8-week dosing in kidney transplantation; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bela

Snippet

Sponsor: Emory University | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2020-09-18